{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:49:43Z","timestamp":1763999383739,"version":"3.45.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T00:00:00Z","timestamp":1762473600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Z Gerontol Geriat"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1007\/s00391-025-02516-3","type":"journal-article","created":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:13:09Z","timestamp":1762506789000},"page":"694-703","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["\u201eS3-Leitlinie zur Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit\u201c","S3 guidelines on the diagnostics, treatment and aftercare of peripheral arterial occlusive disease"],"prefix":"10.1007","volume":"58","author":[{"given":"Christoph","family":"Ploenes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,7]]},"reference":[{"issue":"S113","key":"2516_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1024\/0301-1526\/a001171","volume":"54","author":"N Malyar","year":"2025","unstructured":"Malyar\u00a0N, Behrendt\u00a0CA, Espinola-Klein\u00a0C et\u00a0al (2025) S3-Leitlinie zur Diagnostik, Therapie und Nachsorge der peripheren arteriellen Verschlusskrankheit. Vasa 54(S113):1\u2013119. https:\/\/doi.org\/10.1024\/0301-1526\/a001171","journal-title":"Vasa"},{"issue":"1","key":"2516_CR2","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/S0021-9150(03)00204-1","volume":"172","author":"C Diehm","year":"2004","unstructured":"Diehm\u00a0C, Schuster\u00a0A, Allenberg\u00a0JR et\u00a0al (2004) High prevalence of peripheral arterial disease and co-morbidity in 6880 primary care patients: cross-sectional study. Atherosclerosis 172(1):95\u2013105","journal-title":"Atherosclerosis"},{"issue":"4","key":"2516_CR3","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1007\/s10654-006-0015-9","volume":"21","author":"K Kr\u00f6ger","year":"2006","unstructured":"Kr\u00f6ger\u00a0K, Stang\u00a0A, Kondratieva\u00a0J et\u00a0al (2006) Prevalence of peripheral arterial disease\u2014results of the Heinz Nixdorf recall study. Eur J Epidemiol 21(4):279\u2013285","journal-title":"Eur J Epidemiol"},{"issue":"8","key":"2516_CR4","doi-asserted-by":"publisher","first-page":"e1020","DOI":"10.1016\/S2214-109X(19)30255-4","volume":"7","author":"P Song","year":"2019","unstructured":"Song\u00a0P, Rudan\u00a0D, Zhu\u00a0Y, Fowkes\u00a0FJI et\u00a0al (2019) Global, regional, and national prevalence and risk factors for peripheral artery disease in 2015: an updated systematic review and analysis. Lancet Glob Health 7(8):e1020\u2013e1030","journal-title":"Lancet Glob Health"},{"key":"2516_CR5","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.atherosclerosis.2021.03.019","volume":"325","author":"L Makowski","year":"2021","unstructured":"Makowski\u00a0L, Feld\u00a0J, K\u00f6ppe\u00a0J, Illner\u00a0J et\u00a0al (2021) Sex related differences in therapy and outcome of patients with intermittent claudication in a\u00a0real-world cohort. Atherosclerosis 325:75\u201382","journal-title":"Atherosclerosis"},{"issue":"1","key":"2516_CR6","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ejvs.2019.08.006","volume":"59","author":"T Kreutzburg","year":"2020","unstructured":"Kreutzburg\u00a0T, Peters\u00a0F, Rie\u00df\u00a0HC et\u00a0al (2020) Editor\u2019s Choice\u2014Comorbidity Patterns Among Patients with Peripheral Arterial Occlusive Disease in Germany: A\u00a0Trend Analysis of Health Insurance Claims Data. Eur J Vasc Endovasc Surg 59(1):59\u201366","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"6","key":"2516_CR7","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1024\/0301-1526\/a000966","volume":"50","author":"A Kotov","year":"2021","unstructured":"Kotov\u00a0A, Peters\u00a0F, Debus\u00a0ES et\u00a0al (2021) The prospective GermanVasc cohort study. Vasa 50(6):446\u2013452","journal-title":"Vasa"},{"issue":"1","key":"2516_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2007.02.046","volume":"100","author":"D Mukherjee","year":"2007","unstructured":"Mukherjee\u00a0D, Eagle\u00a0KA, Kline-Rogers\u00a0E et\u00a0al (2007) Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol 100(1):1\u20136","journal-title":"Am J Cardiol"},{"issue":"9901","key":"2516_CR9","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","volume":"382","author":"FG Fowkes","year":"2013","unstructured":"Fowkes\u00a0FG, Rudan\u00a0D, Rudan\u00a0I et\u00a0al (2013) Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a\u00a0systematic review and analysis. Lancet 382(9901):1329\u20131340","journal-title":"Lancet"},{"issue":"4","key":"2516_CR10","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1053\/j.ajkd.2012.02.340","volume":"60","author":"PS Garimella","year":"2012","unstructured":"Garimella\u00a0PS, Hart\u00a0PD, O\u2019Hare\u00a0A, DeLoach\u00a0S, Herzog\u00a0CA, Hirsch\u00a0AT (2012) Peripheral artery disease and CKD: a\u00a0focus on peripheral artery disease as a\u00a0critical component of CKD care. Am J Kidney Dis 60(4):641\u2013654","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"2516_CR11","doi-asserted-by":"publisher","first-page":"1758","DOI":"10.1016\/j.jvs.2017.04.048","volume":"66","author":"K Morisaki","year":"2017","unstructured":"Morisaki\u00a0K, Yamaoka\u00a0T, Iwasa\u00a0K, Ohmine\u00a0T (2017) Influence of frailty on treatment outcomes after revascularizationinpatientswith critical limbischemia. JVascSurg 66(6):1758\u20131764. https:\/\/doi.org\/10.1016\/j.jvs.2017.04.048","journal-title":"JVascSurg"},{"key":"2516_CR12","unstructured":"European Society of Urogenital Radiology ESUR Leitlinien f\u00fcr Kontrastmittel. Version 10.0 2022. Verf\u00fcgbar unter. https:\/\/www.esur.org\/wp-content\/uploads\/2022\/03\/ESUR-V0-Deutsch.pdf. Zugegriffen: 27. M\u00e4rz 2024"},{"key":"2516_CR13","unstructured":"Bundes\u00e4rztekammer, Kassen\u00e4rztliche Bundesvereinigung, Arbeitsgemeinschaft der Wissenschaftlichen Medizinischen Fachgesellschaften (2023) Nationale VersorgungsLeitlinie Typ-2-Diabetes \u2013 Langfassung. Version\u00a03.0 AWMF-Register Nr. nvl-001. https:\/\/www.leitlinien.de\/themen\/diabetes"},{"issue":"7329","key":"2516_CR14","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists C.","year":"2002","unstructured":"Antithrombotic Trialists C. (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324(7329):71\u201386","journal-title":"BMJ"},{"issue":"21","key":"2516_CR15","doi-asserted-by":"publisher","first-page":"1994","DOI":"10.1056\/NEJMoa2000052","volume":"382","author":"MP Bonaca","year":"2020","unstructured":"Bonaca\u00a0MP, Bauersachs\u00a0RM, Anand\u00a0SS et\u00a0al (2020) Rivaroxaban in Peripheral Artery Disease after Revascularization. N\u00a0Engl J Med 382(21):1994\u20132004","journal-title":"N Engl J Med"},{"issue":"14","key":"2516_CR16","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1056\/NEJMoa1709118","volume":"377","author":"JW Eikelboom","year":"2017","unstructured":"Eikelboom\u00a0JW, Connolly\u00a0SJ, Bosch\u00a0J et\u00a0al (2017) Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease. N\u00a0Engl J Med 377(14):1319\u20131330","journal-title":"N Engl J Med"},{"issue":"10390","key":"2516_CR17","doi-asserted-by":"publisher","first-page":"1798","DOI":"10.1016\/S0140-6736(23)00462-2","volume":"401","author":"AW Bradbury","year":"2023","unstructured":"Bradbury\u00a0AW, Moakes\u00a0CA, Popplewell\u00a0M et\u00a0al (2023) A\u00a0vein bypass first versus a\u00a0best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase\u00a03\u00a0trial. Lancet 401(10390):1798\u20131809","journal-title":"Lancet"},{"issue":"25","key":"2516_CR18","doi-asserted-by":"publisher","first-page":"2305","DOI":"10.1056\/NEJMoa2207899","volume":"387","author":"A Farber","year":"2022","unstructured":"Farber\u00a0A, Menard\u00a0MT, Conte\u00a0MS et\u00a0al (2022) Surgery or Endovascular Therapy for Chronic Limb-Threatening Ischemia. N\u00a0Engl J Med 387(25):2305\u20132316","journal-title":"N Engl J Med"},{"issue":"1","key":"2516_CR19","doi-asserted-by":"publisher","first-page":"S120","DOI":"10.1016\/j.ejvs.2019.04.009","volume":"58","author":"JP Simons","year":"2019","unstructured":"Simons\u00a0JP, Schanzer\u00a0A, Flahive\u00a0JM et\u00a0al (2019) Survival prediction in patients with chronic limb-threatening ischemia who undergo infrainguinal revascularization. Eur J Vasc Endovasc Surg 58(1):S120\u2013S134 e123","journal-title":"Eur J Vasc Endovasc Surg"},{"issue":"1","key":"2516_CR20","doi-asserted-by":"publisher","first-page":"220\u2013234","DOI":"10.1016\/j.jvs.2013.08.003","volume":"59","author":"JL Mills Sr.","year":"2014","unstructured":"Mills\u00a0JL Sr., Conte\u00a0MS, Armstrong\u00a0DG et\u00a0al (2014) The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection (WIfI). J\u00a0Vasc Surg 59(1):220\u2013234\u2013e221\u2013222","journal-title":"J Vasc Surg"},{"issue":"8","key":"2516_CR21","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/bjs.4629","volume":"91","author":"DT Ubbink","year":"2004","unstructured":"Ubbink\u00a0DT, Vermeulen\u00a0H, Spincemaille\u00a0GH, Gersbach\u00a0PA, Berg\u00a0P, Amann\u00a0W (2004) Systematic review and meta-analysis of controlled trials assessing spinal cord stimulation for inoperable critical leg ischaemia. Br J Surg 91(8):948\u2013955","journal-title":"Br J Surg"},{"issue":"21","key":"2516_CR22","doi-asserted-by":"publisher","first-page":"2053","DOI":"10.1161\/CIRCULATIONAHA.109.865600","volume":"120","author":"C Diehm","year":"2009","unstructured":"Diehm\u00a0C, Allenberg\u00a0JR, Pittrow\u00a0D, Mahn\u00a0M, Tepohl\u00a0G, Haberl\u00a0RL et\u00a0al (2009) Mortality and vascular morbidity in older adults with asymptomatic versus symptomatic peripheral artery disease. Circulation 120(21):2053\u20132061","journal-title":"Circulation"},{"issue":"5\u20136","key":"2516_CR23","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.jdmv.2021.10.003","volume":"46","author":"A Yannoutsos","year":"2021","unstructured":"Yannoutsos\u00a0A, Lin\u00a0F, Gaisset\u00a0R, Jaillette\u00a0C, Lazareth\u00a0I, Emmerich\u00a0J, Priollet\u00a0P (2021) Characteristics and outcomes of octogenarians with revascularized critical limb ischemia: Impact of altered cardiac function for earlymortality. Jmed Vasc 46(5\u20136):224\u2013231. https:\/\/doi.org\/10.1016\/j.jdmv.2021.10.003","journal-title":"Jmed Vasc"},{"issue":"2","key":"2516_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3400\/avd.oa.18-00167","volume":"12","author":"R Taniguchi","year":"2019","unstructured":"Taniguchi\u00a0R, Deguchi\u00a0J, Hashimoto\u00a0T, Sato\u00a0O (2019) Sarcopenia as a\u00a0possible negative predictor of limb salvage in patients with chronic limb-threateningIschemia. AnnVascDis 12(2):194\u2013199. https:\/\/doi.org\/10.3400\/avd.oa.18-00167","journal-title":"AnnVascDis"},{"issue":"1","key":"2516_CR25","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1002\/ccd.29949","volume":"99","author":"J Li","year":"2022","unstructured":"Li\u00a0J, Arora\u00a0S, Ikeoka\u00a0K, Smith\u00a0J, Dash\u00a0S, Kimura\u00a0S, Mously\u00a0H, Hammad\u00a0TA, Kashyap\u00a0V, Shishehbor\u00a0MH (2022) The utility of geriatric nutritional risk index to predictoutcomes in chronic limb-threatening ischemia. Catheter Cardiovasc Interv 99(1):121\u2013133. https:\/\/doi.org\/10.1002\/ccd.29949","journal-title":"Catheter Cardiovasc Interv"},{"issue":"6","key":"2516_CR26","doi-asserted-by":"publisher","first-page":"2065","DOI":"10.1016\/j.jvs.2019.08.245","volume":"71","author":"JP Roijers","year":"2020","unstructured":"Roijers\u00a0JP, Rakk\u00e9\u00a0YS, Hopmans\u00a0CJ et\u00a0al (2020) A mortality prediction model for elderly patients with critical limb ischemia. J\u00a0Vasc Surg 71(6):2065\u20132072.e2. https:\/\/doi.org\/10.1016\/j.jvs.2019.08.245","journal-title":"J Vasc Surg"},{"issue":"7","key":"2516_CR27","doi-asserted-by":"publisher","first-page":"e6778","DOI":"10.1161\/CIRCINTERVENTIONS.118.006778","volume":"11","author":"Y Takeji","year":"2018","unstructured":"Takeji\u00a0Y, Yamaji\u00a0K, Tomoi\u00a0Y et\u00a0al (2018) Impact of frailty on clinical outcomes in patients with critical limb Ischemia. Circcardiovasc Interv 11(7):e6778 (https:\/\/doi.org\/10.1161\/CIRCINTERVENTIONS.118.006778)","journal-title":"Circcardiovasc Interv"},{"issue":"5","key":"2516_CR28","doi-asserted-by":"publisher","first-page":"e180214","DOI":"10.1001\/jamasurg.2018.0214","volume":"153","author":"R Shah","year":"2018","unstructured":"Shah\u00a0R, Attwood\u00a0K, Arya\u00a0S et\u00a0al (2018) Association of frailty with failure to rescue after low-risk and high-risk inpatient surgery. JAMA Surg 153(5):e180214. https:\/\/doi.org\/10.1001\/jamasurg.2018.0214","journal-title":"JAMA Surg"},{"issue":"24","key":"2516_CR29","doi-asserted-by":"publisher","first-page":"e23138","DOI":"10.1161\/JAHA.121.023138","volume":"10","author":"NM Butala","year":"2021","unstructured":"Butala\u00a0NM, Raja\u00a0A, Xu\u00a0J, Strom\u00a0JB, Schermerhorn\u00a0M, Beckman\u00a0JA, Shishehbor\u00a0MH, Shen\u00a0C, Yeh\u00a0RW, Secemsky\u00a0EA (2021) Association of frailty with treatment selection and long-term outcomes among patients with chronic limb-threatening Ischemia. JAmHeartAssoc 10(24):e23138. https:\/\/doi.org\/10.1161\/JAHA.121.023138","journal-title":"JAmHeartAssoc"},{"issue":"4","key":"2516_CR30","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.ejvs.2012.06.028","volume":"44","author":"Y Sasajima","year":"2012","unstructured":"Sasajima\u00a0Y, Sasajima\u00a0T, Azuma\u00a0N, Akazawa\u00a0K, Saito\u00a0Y, Inaba\u00a0M et\u00a0al (2012) Factors related to postoperative delirium in patients with lower limb ischaemia: a\u00a0prospective cohort study. Eur J Vasc Endovasc Surg 44(4):411\u2013415","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"2516_CR31","doi-asserted-by":"publisher","first-page":"c1718","DOI":"10.1136\/bmj.c1718","volume":"340","author":"S Bachmann","year":"2010","unstructured":"Bachmann\u00a0S, Finger\u00a0C, Huss\u00a0A, Egger\u00a0M, Stuck\u00a0AE, Clough-Gorr\u00a0KM (2010) Inpatient rehabilitation specifically designed for geriatric patients: systematic review and meta-analysis of randomised controlled trials. BMJ 340:c1718","journal-title":"BMJ"}],"container-title":["Zeitschrift f\u00fcr Gerontologie und Geriatrie"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-025-02516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00391-025-02516-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00391-025-02516-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,24]],"date-time":"2025-11-24T15:46:37Z","timestamp":1763999197000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00391-025-02516-3"}},"subtitle":["Wesentliche Aussagen und Implikationen f\u00fcr die Geriatrie","Key points and implications for geriatrics"],"short-title":[],"issued":{"date-parts":[[2025,11,7]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["2516"],"URL":"https:\/\/doi.org\/10.1007\/s00391-025-02516-3","relation":{},"ISSN":["0948-6704","1435-1269"],"issn-type":[{"type":"print","value":"0948-6704"},{"type":"electronic","value":"1435-1269"}],"subject":[],"published":{"date-parts":[[2025,11,7]]},"assertion":[{"value":"3 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"Gem\u00e4\u00df den Richtlinien des Springer Medizin Verlags werden Autoren und Wissenschaftliche Leitung im Rahmen der Manuskripterstellung und Manuskriptfreigabe aufgefordert, eine vollst\u00e4ndige Erkl\u00e4rung zu ihren finanziellen und nichtfinanziellen Interessen abzugeben.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"C.\u00a0Ploenes\n                      : A.\u00a0Finanzielle Interessen: Eingeladener Referent bei Jahreskongressen der Deutschen Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie (Kostenerstattung).\u00a0\u2013 B.\u00a0Nichtfinanzielle Interessen: Chefarzt Fachabteilung f\u00fcr Angiologie, Sch\u00f6n-Klinik D\u00fcsseldorf | Mitgliedschaften: Deutsche Gesellschaft f\u00fcr Geriatrie, Deutsche Gesellschaft f\u00fcr Gef\u00e4\u00dfchirurgie, Deutsche Gesellschaft f\u00fcr Angiologie | Moderator der Arbeitsgruppe Gef\u00e4\u00dferkrankungen der Deutschen Gesellschaft f\u00fcr Geriatrie.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Autoren"}},{"value":"Die vollst\u00e4ndige Erkl\u00e4rung zum Interessenkonflikt der Wissenschaftlichen Leitung finden Sie am Kurs der zertifizierten Fortbildung auf\n                      \n                      .","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Wissenschaftliche Leitung"}},{"value":"erkl\u00e4rt, dass f\u00fcr die Publikation dieser CME-Fortbildung keine Sponsorengelder an den Verlag flie\u00dfen.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}},{"value":"F\u00fcr diesen Beitrag wurden von den Autor\/-innen keine Studien an Menschen oder Tieren durchgef\u00fchrt. F\u00fcr die aufgef\u00fchrten Studien gelten die jeweils dort angegebenen ethischen Richtlinien.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Der Verlag"}}]}}